n-3 Polyunsaturated Fatty Acids in Obesity

NCT00760760 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Adipose Tissue Inflammation
Morbid Obesity

Interventions

DRUG: reesterified long-chain n-3 polyunsaturated fatty acids (EPA, DHA)
DRUG: control

Sponsor

Medical University of Vienna

Collaborators

[object Object]